Enhanced Hepatitis Strain & Surveillance System (EHSSS) in Review BCCDC Hepatitis Services Site 2000-2009 Site Investigator: Liza McGuinness Overview BCCDC EHSSS - Public Health Agency of Canada sponsored project Two major goals: Obtain more accurate assessment of current infection levels Track HBV & HCV transmission risk factors BCCDC site in BC: Responsible for province of BC (excludes City of Vancouver) Coordinated out of BC Hepatitis Services Follows all acute HBV and HCV 2 Overview Between 2000-2009 1060 individuals identified as of Feb 12, 2010 305 Acute HBV, 748 Acute HCV, 7 Acute HBV/HCV co-infection HCV numbers increasing/HBV numbers decreasing 120 107 100 91 89 74 80 80 82 75 60 55 51 44 50 40 20 29 42 29 32 33 33 17 22 18 0 2000 2001 2002 2003 2004 HCV 2005 2006 HBV 2007 2008 2009 3 Case Definitions Acute HBV HBsAg and HBcIgM reactive with compatible clinical history and symptoms Acute HCV Seroconversion from anti-HCV nonreactive to anti-HCV reactive within 12 months 4 Challenges Centralized acute HCV surveillance Limited ability to contact acute HCV across the province from the BCCDC Corrections Restricted or no access to individuals who test positive in federal or provincial corrections 5 Initiatives Regular reconciliation process ongoing with lab, iPHIS & Vancouver EHSSS Regional Health Authorities assuming EHSSS follow up for acute HCV Future: federal & provincial corrections re: information access 6 For all mono-infected cases 2000-2009 n= 305 acute HBV, n= 748 acute HCV 7 Acute HBV Cases by Age 100% 80% 60% 40% 20% 0% 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Total 50 + yrs. 9 13 4 9 8 8 7 5 9 9 81 40 to 49 yrs. 8 12 8 4 9 15 6 4 6 4 76 30 to 39 yrs. 4 12 5 11 10 15 11 6 5 4 83 20 to 29 yrs. 8 12 12 7 6 4 7 1 2 1 60 0 to 19 yrs. 0 1 0 1 0 0 2 1 0 0 5 8 Acute HBV Cases by Gender 100% 80% 60% 21 32 20 23 26 30 7 12 14 22 15 15 218 40% 20% 8 18 9 9 2 3 87 20 00 20 01 20 02 20 03 20 04 20 05 20 06 20 07 20 08 20 09 To ta l 0% 8 11 Infection predominates in males Female Male 9 Acute HBV Cases by Health Authority 100% 80% 60% 40% 20% 0% * 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Total Vancouver Coastal 4 5 2 5 5 1 4 0 0 2 28 Northern 2 4 3 0 0 3 2 0 0 1 15 Interior 3 5 2 3 3 9 4 2 3 2 36 Vancouver Island 9 14 8 13 12 9 4 5 4 3 81 Fraser 11 22 14 11 13 20 19 10 15 10 145 * Vancouver Coastal Cases exclude the City of Vancouver 10 Acute HCV Cases by Age 100% 80% 60% 40% 20% 0% 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Total 50 + yrs. 2 2 2 1 4 2 7 5 12 5 42 40 to 49 yrs. 5 8 9 9 14 7 18 16 17 12 115 30 to 39 yrs. 12 33 19 33 17 17 21 29 35 15 231 20 to 29 yrs. 18 40 17 24 39 23 33 28 37 36 295 7 8 4 7 8 6 10 2 6 7 65 0 to 19 yrs. 11 Acute HCV Cases by Gender 100% 80% 20 46 25 36 43 26 43 41 49 32 361 60% Male Female 40% 24 20% 45 26 38 39 29 46 39 58 43 387 20 00 20 01 20 02 20 03 20 04 20 05 20 06 20 07 20 08 20 09 To ta l 0% 83% (54/65) of those 19 or under diagnosed with acute HCV are female 12 Acute HCV Cases by Health Authority 100% 80% 60% 40% 20% 0% * 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Total Vancouver Coastal 6 5 2 8 8 2 2 1 5 5 44 Northern 2 13 5 7 13 4 13 11 12 10 90 Interior 10 16 10 8 8 11 17 15 11 11 117 Vancouver Island 11 25 13 27 20 14 18 12 22 9 171 Fraser 14 32 21 24 33 23 37 41 56 39 320 * Vancouver Coastal Cases do not include City of Vancouver † 6 cases not listed on chart originated in the Yukon 13 Acute HBV/HCV Co-infection 7 cases since 2000 (no new cases 2007-9) 5 males 30-49 yrs; 2 females 20-29 yrs 5 cases in VIHA, 1 in Interior, 1 in Fraser 4 consecutive cases in Victoria from 2003-06 5 interviews 2 had incarceration, sexual, IDU* & NIDU** risk factors 2 had sexual, IDU and NIDU risk factors 1 had been incarcerated & had sexual and NIDU risk factors * Injection Drug Use = IDU ** Non Injection Drug Use (Smoking crack pipes or snorting) = NIDU 14 For all mono-infected cases for 2000-2009 n=177/305 acute HBV, n=185/748 acute HCV 15 Acute HBV Interviews by Year 100% 1 1 1 2 5 1 5 2 2 5 9 8 9 80% 4 60% 17 1 3 2 5 3 3 2 26 19 10 1 34 40% 20% 1 1 31 20 22 10 15 10 14 0% 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Interviewed Unable to locate Refused Died Language Barrier 16 Acute HCV Interviews by Year 1 1 5 100% 3 1 4 1 9 13 8 7 1 5 17 80% 15 60% 25 62 39 4 3 2 1 7 * 36 38 36 69 25 69 46 40% 20% 10 14 23 26 32 28 11 9 12 0% 24 6 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Interviewed Died Unable to locate Language Barrier Refused Corrections * Includes 5 cases still in follow up 17 For interviewed 2000-2009 acute HBV (n=177) and HCV (n=185) 18 Acute HBV Risk factors 2000-09 In the previous 12 mo’s before diagnosis: Only 1 risk factor identified (74/177, 42%) 69/177, 39% - only sexual risk factors 3/177, 2% - only used injection drugs 2/177, 1% - only used non-injection drugs 19 Acute HBV Risk factors 2000-09 In the previous 12 mos before diagnosis: Risk factor combinations (43/177, 24%) 20/177, 11% - non-injection drug & sexual risk factors 9/177, 5% - injection & non-injection drug use & sexual risk factors 6/177, 3% - injection & non-injection drug use, sex & incarceration risk factors (all) 5/177, 3% - injection drug use & sexual risk factors 3/177, 2% - injection & non-injection drug use (Other risk factors or combinations = 7/177, 7%; No risk factors = 52/177, 29%) 20 Acute HBV Risk factors 2000-09 In the previous 12 mos before diagnosis: 30/177, 17% - injection drug use – in only 3 cases was single risk factor 13/177, 7% - incarcerated – all in combination with drug use (10 IDU & NIDU, 3 NIDU only) 21 Acute HBV Risk Factors 2000-09 Lifetime risk factors: 160 140 149 120 100 80 60 71 40 47 20 43 23 0 Diff Sex NIDU 2000-2009 IDU Incarceration Same sex Different = sex with different gender; Same sex = sex with same gender 22 Acute HBV IDU Proportions 100% 80% 10 8 60% 19 22 16 9 17 8 12 2 3 130 9 40% 10 6 20% 7 0% 1 3 9 5 47 1 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 Total Reporting IDU as a risk factor Not-reporting IDU as a risk factor 23 HBV Risk Factors 2000-09 16 cases did not report drug use, prison and/or sex risk factors 3 – Medical exposure during travel to India 2 - Travel to foreign country 3 - No risk factors identified from interview 2 - Vertical transmission 1 – Other horizontal transmission 5 - Medical Related 1 - Reported only medical procedure 1 - Reported only surgery and acupuncture 1 - Reported only blood transfusion 1 - Reported only medical procedure and dental surgery 1 – Reported injection from alternative practitioner 24 Acute HCV Risk factors 2000-09 In the previous 12 mo’s before diagnosis: Only 1 risk factor identified (34/185, 18%) 13/185, 7% - injection drug use only 13/185, 7% - only sexual risk factors 7/185, 4% - non-injection drug use only 1/185, <1% - incarceration only 25 Acute HCV Risk factors 2000-09 In the previous 12 mo’s before diagnosis: 130/185, 70% - injection drug use (13/129 cases = single risk factor) 27/185, 15% - had been incarcerated (1/27 case = single risk factor) 26 Acute HCV Risk Factors Lifetime risk factors: 180 160 173 140 150 120 154 100 80 60 65 40 40 20 0 2000-2009 Diff sex NIDU IDU Incarceration Same sex 27 HCV Risk Factors 2000-09 4 cases reported no lifetime drug use, prison or sex risk factors 1 - Dialysis in India 1 - Reported only medical procedure 1 - Reported other exposure to needles & medical procedure (declined diff sex risk factor Q) 1 - No risk factors identified from interview 28 HBV & HCV Multiple Risk Factors Number of participants reporting lifetime multiple risk factors for IDU, NIDU, Different-Sex, Same-Sex and Incarceration: 70 70 69 58 60 50 40 33 32 33 30 22 20 10 14 8 2 0 1 Risk Factor 2 Risk Factors 3 Risk Factors HBV HCV 4 Risk Factors 5 Risk Factors 29 HBV & HCV Multiple Risk Factors Lifetime risk factor combinations 1 2 Risk Factor Risk Factors Sex n=76/177 NIDU & Sex n=18/177 HBV 43% 10% 3 4 Risk Factors Risk Factors IDU, NIDU & Sex n=16/177 IDU, NIDU, Incarceration & Sex n=21/176 %9 12% Sex n=10/185 IDU & Sex n=19/185 IDU, NIDU & Diff sex n=71/185 IDU, NIDU, Incarceration & Sex n=56/185 5% 10% 38% 30% HCV Increased % of acute HCV cases with multiple risk factors 30 Summary Acute Hepatitis B Identified acute cases decreasing Sexual exposure most predominant risk factor Vaccination of those at risk in prison is important 31 Summary Hepatitis C Virus Identified acute cases increasing Acute infections identified in youth occurring predominately in females Unclear if due to testing bias or increased risk Higher % of acute HCV clients present with multiple risk factors compared to acute HBV IDU primary transmission mode reported Incarceration remains an important correlate 32 Acknowledgements Thanks to Amanda Yu for her statistical expertise and to our partners in public health who conduct interviews on behalf of the EHSSS 33